pcsk9

Documents about pcsk9

• Application of PCSK9 Inhibitors in Patients With Heterozygous Familial Hypercholesterolemia#1183353ClinicalTrials.gov
• Sex Hormones and Blood PCSK9 Levels#883456ClinicalTrials.gov
• PCSK9 Inhibitors in the Progression of Aortic Stenosis#992024ClinicalTrials.gov
• Effect of PCSK9 Inhibitors on Calcific Aortic Valve Stenosis#901075ClinicalTrials.gov
• PCSK9 inhibitors patterns of use in France from nationwide repeated cross-sectional and cohort studies#15491HAL (France)
• Cholesterol Disruption in Combination With the Standard of Care in Patients With Advanced Pancreatic Adenocarcinoma#1033649ClinicalTrials.gov
• Efficacy and Safety of Pitavastatin and PCSK9 Inhibitors in Liver Transplant Patients#1445171ClinicalTrials.gov
• PCSK9 in vascular smooth muscle cells: biology, pathology, and inhibition to fight atherosclerosis#257724HAL (France)
• PCSK9 and inflammation: A review of experimental and clinical evidence#948268Repositorio de Universidad Autónoma de Chile.
• Study to Evaluate Changes in Cognitive Function in Patients Treated With PCSK9 Inhibitors#837275ClinicalTrials.gov
• Trial of PCSK9 Inhibition in Patients with Acute Stroke and Symptomatic Intracranial Atherosclerosis#1396983ClinicalTrials.gov
• Implication of Lipids in Calcified Aortic Valve Pathogenesis: Why Did Statins Fail?#274371HAL (France)
• Sequence Variations in <i>PCSK9,</i> Low LDL, and Protection against Coronary Heart Disease#400175OpenAlex
• COPANA - A09 PCSK 9 Substudy: Impact of Protease Inhibitors on PCSK9 Levels in Naive HIV-Infected Patients#810560ClinicalTrials.gov
• Very Early PCSK9 Inhibition for Acute Myocardial Infarction#896751ClinicalTrials.gov
• Trial Assessing Long Term USe of PCSK9 Inhibition in Subjects With Genetic LDL Disorders#1454022ClinicalTrials.gov
• PCSK9 Inhibitor With Statin Therapy for Asymptomatic Intracranial Atherosclerosis#850065ClinicalTrials.gov
• Reduction of Low-Density Lipoprotein Cholesterol (LDL-C) With PCSK9 Inhibition in Heterozygous Familial Hypercholesterolemia Disorder Study#1074433ClinicalTrials.gov
• PCSK9 as a mediator of monocytes transendothelial activation in obstructive sleep apnoea: A translational study#1537875HAL (France)
• The Effect of Early Administration of PCSK9 Inhibitor to Acute Ischemic Stroke Patients Associated With Atherosclerosis on the Stroke Prognosis and Lipid Profile#895543ClinicalTrials.gov
• A Study of PCSK9 Inhibitor AK102 in Healthy Subjects#850756ClinicalTrials.gov
• Single Dose PCSK9 Inhibitor to Improve Cardiovascular Outcomes After PCI: A Pilot Study#1094684ClinicalTrials.gov
• Efficacy and Safety of PCSK9 Inhibitors in Patients With Large-Artery Atherosclerosis (LAA) Ischemic Stroke#1321813ClinicalTrials.gov
• Assessing Coronary Non-Culprit Plaque Early with Start of PCSK9 Inhibitors in Acute Myocardial Infarction (ACCESS-AMI)#1128023ClinicalTrials.gov
• A Study to Assess the Real-World Effectiveness of Inclisiran and PCSK9 mAbs in Chinese Hypercholesterolemia Adult Patients#1280835ClinicalTrials.gov
• Study on the Composite Endpoint Event of PCSK9 Inhibitor in Patients With Very High Risk of ASCVD and Cancer#1410857ClinicalTrials.gov
• Impact of a Structured Educational Intervention on Knowledge, Attitudes, and Prescribing Perceptions Regarding PCSK9 Inhibitors Among Healthcare Professionals in Saudi Arabia: A Pre-Post Interventional Study#427379HAL (France)
• Early Administration of PCSK9 Inhibitors After Thrombectomy for Atherosclerotic Acute Ischemic Stroke: A Randomized Controlled Trial#1310373ClinicalTrials.gov
• Real World Adherence of PCSK9 Targeted Therapy#1340391ClinicalTrials.gov
• Tafolecimab in Hyperlipidemia: A Study of Different Dosing Intervals#1431091ClinicalTrials.gov
• Genetic and In Vitro Inhibition of PCSK9 and Calcific Aortic Valve Stenosis#322476HAL (France)
• PCSK9 Confers Inflammatory Properties to Extracellular Vesicles Released by Vascular Smooth Muscle Cells#424946IRIS
• Efficacy and Safety of Bempedoic Acid in Association With Anti-PCSK9 and Ezetimibe in Statin-intolerant Patients#1465874ClinicalTrials.gov
• Trial Assessing Efficacy, Safety and Tolerability of Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition in Paediatric Subjects With Genetic Low-Density Lipoprotein (LDL) Disorders#1463790ClinicalTrials.gov
• Short-term Effect of PCSK9 Inhibitor in Patients With Acute Ischemic Stroke#414417ClinicalTrials.gov
• Evolocumab in STEMI#1261151ClinicalTrials.gov
• Kinetic Study of Lp(a) and PCSK9 in Humans#1370642ClinicalTrials.gov
• In Vitro Demonstration of Direct Platelet-Related Effects of PCSK9 Enzyme#123431ClinicalTrials.gov
• Pharmacodynamic Biomarkers to Support Biosimilar Development: PCSK9 Inhibitors#1033163ClinicalTrials.gov
• Study Assessing Safety, Immunogenicity and LDLc -Lowering Activity of 2 PCSK9 Targeting AFFITOPE Vaccines in Healthy Subjects#261329ClinicalTrials.gov
• Relationships Between Plasma PCSK9 Levels, LDL-cholesterol Concentrations and Lipoprotein (a) Levels in Familial Hypercholesterolemia#1308354ClinicalTrials.gov
• Effect of PCSK9-Antibody (Alirocumab) on Dyslipidemia Secondary to Nephrotic Syndrome#1352941ClinicalTrials.gov
• Impact of PCSK9 Inhibitors on Coronary Microvascular Dysfunction in Patients With Atherosclerotic Cardiovascular Disease Proved by Myocardial Ischemia and Needing Coronarography#1376461ClinicalTrials.gov
• Exploring the Other Side of Medication: A Patient Interview Study on Anti-PCSK9 Monoclonal Antibodies.#288876NCBI PubMed Central
• Proprotein Convertase Subtilisin Kexin 9 in Rheumatoid Arthritis#834435ClinicalTrials.gov
• Anti-PCSK9 Antibody Tafolecimab and Anti-PD-1 Antibody Sintilimab Combined With Neoadjuvant Chemoradiotherapy for pMMR/ MSS Locally Advanced Rectal Cancer : A Prospective, Multicenter, Randomized, Open-Label, Parallel-Controlled Trial#1212737ClinicalTrials.gov
• Combining mRNA display and photo-crosslinking to discover high-affinity photoreactive peptide probes for PCSK9#323934Spiral
• PCSK9 Inhibition in Patients With Symptomatic Intracranial Atherosclerosis#854416ClinicalTrials.gov
• PCSK9 inhibitoRs for Early Passivation of coRonary athEroSclerotic plaqueS in Acute Coronary Syndromes (REPRESS)#877748ClinicalTrials.gov
• In-hospital Initiation of PCSK9 Inhibitor in Patients With Acute Myocardial Infarction#905445ClinicalTrials.gov